Melbourne, Australia; Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today announced that as part of its OTCQX  investor communications, a pre-recorded presentation by Chief Executive Officer Dr Jackie Fairley will be broadcast at VirtualInvestorConferences.com on Thursday, October 1, 2015 at 12.15pm (EDT time). The presentation is part of a special OTCQX Life Sciences virtual Conference.

The presentation will provide an overview of the Company for new investors including recent announcements:

• EU marketing approval for VivaGel^® BV; and
• Drug delivery license with AstraZeneca for DEP™ technology.

Interested parties are able to register at www.virtualinvestorconferences.com or at the following link: http://tinyurl.com/101pre .  An on-demand archive will be available for 90 days at www.virtualinvestorconferences.com.   

A copy of the presentation slides is below.

Download ASX Announcement: OTCQX Life Sciences Presentation (pdf file, 990kb)